VBL and its 'gene therapy' cancer treatment are back — with a peek at PhIII potential
Three years after a brain cancer failure sent the company reeling, VBL Therapeutics is touting its first hint of positive Phase III results.
The Israeli …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
